Savings in space, time and profits are just a few of the things cellular manufacturing concepts have going for them. Last month I presented an introduction to work cells by looking back at how ...

Cellular manufacturing systems (CMS) represent a pivotal approach to modern industrial production, in which machines and workstations are organised into discrete cells dedicated to the manufacture of ...

CAMBRIDGE, England & STEVENAGE, England--(BUSINESS WIRE)--Cellular Origins, a TTP Company focused on enabling scalable, cost-effective, and efficient manufacture of cell and gene therapies (CGTs), and ...

B&B Manufacturing re-arranges machines into cells, some of which can be dedicated to one customer’s parts. While B&B Manufacturing Co. Inc discribes itself as a job shop, it seems to have the level of ...

Cellular Origins, a TTP Company focused on enabling scalable, cost-effective, and efficient manufacture of cell and gene therapies (CGTs), has today announced a collaborative partnership with ...

Cellular Origins, a TTP company, acquired the ACTIA (Autologous Cell Therapy Industrial Automation) Platform IP, developed by Geoff Hodge while CEO of SOTIO Biotech US. The ACTIA Platform complements ...

CAMBRIDGE, England--(BUSINESS WIRE)--Cellular Origins, a TTP Company, focused on enabling scalable, cost-effective, and efficient manufacture of cell and gene therapies (CGTs), today announced a ...

This is a preview. Log in through your library . Abstract This paper is both an extension and an expansion of two earlier studies concerned with the direction of OR/MS research as reported in its ...

Cellular Origins and Fresenius Kabi, an operating company of Fresenius, announce today they have signed a development agreement that leverages each company’s expertise in cell and gene therapies (CGTs ...

Cellular and gene therapy fields are currently on track for, if not already experiencing, a serious capacity crunch. Current cellular and gene therapies, those relatively few marketed and the hundreds ...